Schechter Investment Advisors LLC Buys 158 Shares of Colgate-Palmolive (NYSE:CL)

Schechter Investment Advisors LLC raised its stake in Colgate-Palmolive (NYSE:CL) by 6.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,811 shares of the company’s stock after acquiring an additional 158 shares during the period. Schechter Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $256,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Swedbank AB boosted its holdings in Colgate-Palmolive by 1.4% in the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after acquiring an additional 40,324 shares during the last quarter. QRG Capital Management Inc. boosted its stake in shares of Colgate-Palmolive by 12.3% in the 3rd quarter. QRG Capital Management Inc. now owns 64,342 shares of the company’s stock valued at $6,679,000 after purchasing an additional 7,067 shares during the last quarter. FSM Wealth Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $204,000. Crestwood Advisors Group LLC raised its stake in Colgate-Palmolive by 1.2% during the third quarter. Crestwood Advisors Group LLC now owns 34,176 shares of the company’s stock worth $3,548,000 after buying an additional 407 shares during the last quarter. Finally, Long Run Wealth Advisors LLC acquired a new position in Colgate-Palmolive in the third quarter valued at $207,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.9 %

CL stock opened at $91.87 on Thursday. The firm has a market capitalization of $74.56 billion, a PE ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock’s 50 day moving average is $88.72 and its 200-day moving average is $95.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 EPS. Sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.18%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Analyst Ratings Changes

CL has been the subject of a number of recent analyst reports. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. Piper Sandler reduced their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, UBS Group dropped their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.